Pfizer Inc. (BIT:1PFE)

Italy flag Italy · Delayed Price · Currency is EUR
20.35
-0.34 (-1.64%)
Last updated: Aug 1, 2025
-1.64%
Market Cap121.53B
Revenue (ttm)54.48B
Net Income (ttm)9.18B
Shares Outn/a
EPS (ttm)1.62
PE Ratio13.24
Forward PEn/a
Dividend1.55 (7.61%)
Ex-Dividend DateJul 24, 2025
Volume860
Average Volume4,744
Open20.41
Previous Close20.69
Day's Range20.35 - 20.41
52-Week Range18.73 - 29.03
Betan/a
RSI50.01
Earnings DateAug 5, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Industry Pharmaceutical Preparations
Founded 1849
Employees 81,000
Stock Exchange Borsa Italiana
Ticker Symbol 1PFE
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD Financial Statements

News

There is no news available yet.